ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026

IK-175, an Oral Aryl Hydrocarbon Receptor Inhibitor, Alone and with Nivolumab in Patients with Advanced Solid Tumors and Urothelial Carcinoma.

David H Aggen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.